Ketorine DX Eye Drops contain Ketorolac 0.5% w/v + Dexamethasone 0.1% w/v, a dual-action ophthalmic formulation designed to treat ocular inflammation, pain, and post-operative eye conditions. Its combination provides rapid relief and symptom control through NSAID and steroidal action.
Ketorolac acts as a non-steroidal anti-inflammatory agent, reducing pain and inflammation, while Dexamethasone provides potent steroidal anti-inflammatory action, helping prevent tissue damage and accelerating recovery.
From a commercial perspective, Ketorine DX Eye Drops are a high-prescription ophthalmic anti-inflammatory product, commonly used in eye hospitals, clinics, and post-operative care centers, ensuring steady market demand and repeat prescriptions.
Adding Ketorine DX Eye Drops to your portfolio strengthens the ophthalmic steroid-NSAID segment, offering long-term growth, prescriber confidence, and enhanced portfolio credibility for PCD pharma franchise partners.